Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

RLMD

Relmada Therapeutics Inc

Apr 29 • 04:00PM ET

7.37

+0.13 1.80 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: AXSM SAGE ACAD NBIX VKTX ITCI XENE OVID CORT BHVN

| Held by: VTI VXF PSIL ITOT ONEQ PRFZ IBRN

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.47	Insider Own	12.25%	Shs Outstand	104.89M	Perf Week	4.39%
Market Cap	773.03M	Forward P/E	-	EPS next Y	-0.95	Insider Trans	8.79%	Shs Float	92.04M	Perf Month	15.52%
Enterprise Value	680.02M	PEG	-	EPS next Q	-0.20	Inst Own	46.29%	Short Float	6.73%	Perf Quarter	86.58%
Income	-57.39M	P/S	-	EPS this Y	47.53%	Inst Trans	40.83%	Short Ratio	3.48	Perf Half Y	216.31%
Sales	0.00M	P/B	6.25	EPS next Y	-25.38%	ROA	-82.08%	Short Interest	6.19M	Perf YTD	52.59%
Book/sh	1.18	P/C	8.31	EPS next 5Y	12.34%	ROE	-94.05%	52W High	7.94 -7.18%	Perf Year	2494.16%
Cash/sh	0.89	P/FCF	-	EPS past 3/5Y	35.03% 17.54%	ROIC	-66.33%	52W Low	0.27 2655.14%	Perf 3Y	192.46%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.99% 6.37%	Perf 5Y	-81.02%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	44.57%	Oper. Margin	-	ATR (14)	0.45	Perf 10Y	-42.60%
Dividend Ex-Date	-	Quick Ratio	14.62	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	59.24	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	14.62	EPS Q/Q	52.92%	SMA20	2.68%	Beta	0.41	Target Price	12.80
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	19.05%	Rel Volume	0.48	Prev Close	7.24
Employees	17	LT Debt/Eq	0.00	Earnings	Mar 19 AMC	SMA200	109.85%	Avg Volume	1.78M	Price	7.37
IPO	Jun 20, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-81.70% -	Trades		Volume	846,770	Change	1.80%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)